1. AM-18002, a derivative of natural anmindenol A, enhances radiosensitivity in mouse breast cancer cells.
- Author
-
Eum, Da-Young, Jeong, Myeonggyo, Park, Soon-Yong, Kim, Jisu, Jin, Yunho, Jo, Jeyun, Shim, Jae-Woong, Lee, Seoung Rak, Park, Seong-Joon, Heo, Kyu, Yun, Hwayoung, and Choi, Yoo-Jin
- Subjects
CANCER cells ,MYELOID-derived suppressor cells ,BREAST cancer ,NITRIC-oxide synthases ,CANCER cell migration ,BREAST - Abstract
Natural anmindenol A isolated from the marine-derived bacteria Streptomyces sp. caused potent inhibition of inducible nitric oxide synthase without any significant cytotoxicity. This compound consists of a structurally unique 3,10-dialkylbenzofulvene skeleton. We previously synthesized and screened the novel derivatives of anmindenol A and identified AM-18002, an anmindenol A derivative, as a promising anticancer agent. The combination of AM-18002 and ionizing radiation (IR) improved anticancer effects, which were exerted by promoting apoptosis and inhibiting the proliferation of FM3A mouse breast cancer cells. AM-18002 increased the production of reactive oxygen species (ROS) and was more effective in inducing DNA damage. AM-18002 treatment was found to inhibit the expansion of myeloid-derived suppressor cells (MDSC), cancer cell migration and invasion, and STAT3 phosphorylation. The AM-18002 and IR combination synergistically induced cancer cell death, and AM-18002 acted as a potent anticancer agent by increasing ROS generation and blocking MDSC-mediated STAT3 activation in breast cancer cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF